APPLICATIONS PUBLISHED 10 DECEMBER 2003

Published: 1-May-2004

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial IB-367 peptides
    Intrabiotics Pharmaceuticals 1367980*

  • Hair follicle neogenesis by injection of follicle progenitor cells
    Aderans Research Institute 1367982*

  • Microcapsules with aqueous core containing oxidation-reduction enzymes and their use in oxidation dyeing compsns
    L'Oreal 1367983*

  • Anhydrous antiperspirant and deodorant compsns containing solid D-pantothenate salts
    Procter & Gamble 1367984*

  • Anhydrous antiperspirant and deodorant compsns containing a solid, water-soluble skin active agent
    Procter & Gamble 1367985*

  • Compsn containing a dibenzoyl-methane derivative and an (a)-alkylstyrene dimer, UV stabilising method
    L'Oreal 1367986*

  • Fast dissolving tablets of cyclo-oxygenase-2 enzyme inhibitors
    Ranbaxy Laboratories 1367994*

  • Compsns and methods for enhancing drug delivery across and into epithelial tissues
    Cellgate 1367995*

  • Sustained-release suspension of ceftiofur hydrochloride
    LB Chem Instrument 1367996*

  • Injectible water-in-oil emulsions
    Akzo Nobel 1367997*

  • Methods and compsns relating to hydrogen peroxide and superoxide production by antibodies
    The Scripps Research Institute 1367998*

  • Water soluble and palatable complexes
    Lavipharm Laboratories 1367999*

  • Chronotherapeutic dosage forms containing glucocorticosteroid
    Penwest Pharmaceuticals 1368000*

  • Pharmaceutical formulation comprising bicalutamide
    AstraZeneca 1368001*

  • Method for producing a floating tablet containing afluzosine
    Ellipse Pharmaceuticals 1368002*

  • Methods and compsns for reducing the taste of pharmaceutically active agents
    RP Scherer Technologies 1368003*

  • Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine
    LTS Lohmann Therapie-Systeme 1368004*

  • Chronotherapeutic dosage forms
    Penwest Pharmaceuticals 1368005*

  • Novel modified release dosage formulations
    AstraZeneca 1368006*

  • Coating and binding agent for pharmaceutical formulations with improved storage stability
    Roehm 1368007*

  • Transdermal therapeutic system for the administration of partial dopamine-D2 agonists
    LTS Lohmann Therapie-Systeme 1368008*

  • Aldosterone blocker therapy to prevent or treat inflammatory-related disorders
    Pharmacia Corp 1368009*

  • Antibacterial compsns which contain oxapenem-3-carboxylic acids and antibiotics
    Amura 1368010*

  • Method for treating PPAR gamma mediated diseases
    SmithKline Beecham 1368011*

  • Use of one or more shogaol(s) as an aphrodisiac
    LMD 1368012*

  • Use of cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications
    Meiji Dairies 1368013*

  • Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria
    Meiji Dairies 1368014*

  • Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function
    Novartis 1368015*

  • Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt
    Gruenenthal 1368016*

  • Compounds of biochemical compounds involved in bioenergy metabolism of cells and method of use
    Rath, Matthias 1368017*

  • Use of sugar phosphate, sugar phosphate analogues, amino acids and/or amino acid analogues for modulating the glycolysis-enzyme complex, the malate-aspartate shuttle and/or transaminases
    Schebo Biotech 1368018*

  • Esmolol formulation
    Baxter International 1368019*

  • Method for identifying maxi-K channel blockers
    Merck 1368020*

  • Carbamate compounds for use in preventing or treating bipolar disorder
    Ortho-McNeil Pharmaceuticals 1368021*

  • Device for packaging an oxiplatinum solution
    Debiopharm 1368022*

  • Utilisation of buprenorphrine in urinary incontinence therapy
    Gruenenthal 1368023*

  • Treatment of restenosis
    Novogen Research 1368024*

  • Compsns useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor
    Signa-Tau Industrie Farmaceutiche Riunite 1368025*

  • Use of active substance combinations from alpha lipoic acid and substances that absorb light in the UV-A and/or UV-B range for use in the treatment and/or prophylaxis of undesired cutaneous pigmentation
    Beiersdorf 1368026*

  • Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumours
    Max-Delbrueck-Centrum Fuer Molekulare Medizin 1368027*

  • Benzimidazole compounds for modulating IGE and inhibiting cellular proliferation
    Avanir Pharmaceuticals 1368028*

  • Methods and compsns for rejuvenating cells, tissues, organs, hair and nails
    Farrington Pharmaceuticals 1368029*

  • Epothilone derivatives for the treatment of refractory tumours
    Bristol-Myers Squibb 1368030*

  • Method of treating of demyelinating diseases or conditions
    Aventis Pharmaceuticals 1368031*

  • Excitatory amino acid receptor antagonists
    Eli Lilly 1368032*

  • Method and apparatus for treating breakthrough pain
    Cephalon 1368033*

  • Method and dosage form for treating tumours by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
    Bristol-Myers Squibb 1368034*

  • Use of type 4 phosphodiesterase inhibitors in myocardial disease
    Merck Patent 1368035*

  • Regulation of glucocorticoid concentration
    The University of Edinburgh 1368036*

  • Estrogen replacement therapy
    Wyeth 1368037*

  • Methods for the administration of amfostine and related compounds
    Medimmune Oncology 1368038*

  • Aminoglycoside treatment for lyosomal storage diseases
    The UAB Research Foundation 1368039*

  • Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
    Resprotect 1368040*

  • Amphotericin B aqueous compsn
    Bharat Serums & Vaccines 1368041*

  • Blood brain barrier modulation using stressed autologous blood cells
    Vasogen Ireland 1368043*

  • Immunomodulator for the management of human immunodeficiency virus (HIV) disease/infection
    Bakulesh, Mafatial Khamar; Indravadan, Ambalel Modi 1368044*

  • Process for obtention of decoctions of Vitis labrusca and Vitis vinifera skins
    Universidade do Estado do Rio De Janeiro 1368045*

  • Pharmaceutical formulation and the use thereof for preparing a medicament for the treatment of cardiovascular diseases
    MB Pharmos 1368046*

  • Compsns containing Asiasari radix extracts for protecting brain cells and improving memory
    Kim, Sung-Jin 1368047*

  • Pharmaceutical compsn made of cannabis extracts
    Forschungsinstitut Hiscia Verein Fuer Krebsforschung 1368048*

  • Inhibition of AFT2 activity to treat cancer
    The Mount Sinai School of Medicine of New York University 1368049*

  • Virus derived antimicrobial peptides
    University of Pittsburgh of the Commonwealth System of Higher Education 1368050*

  • Urocortin-III and uses thereof
    Research Development Foundation 1368051*

  • Agents, which inhibit apoptosis in cells that are involved in wound healing
    CytoTools 1368052*

  • Compsns and methods for treating gonadotrophin related illnesses
    Allergan 1368053*

  • Using neural thread proteins to treat tumours and other hyperproliferative disorders
    Nymox Pharmaceuticals Operation 1368054*

  • Combined use of derivatives of GLP-1 analogues and PPAR ligands
    Novo Nordisk 1368055*

  • Recombinant gelatin-like protein proteins for use as plasma expanders
    Fuji Photo Film 1368056*

  • Method to enhance the immunogenicity of an antigen
    Lancell 1368057*

  • Viral reporter particles
    Merck 1368058*

  • Methods of inducing organ transplant tolerance and correcting haemoglobinopathies
    Emory Therapeutics 1368059*

  • HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases
    Bio3 Research 1368060*

  • Fusion cells and cytokine compsns for the treatment of disease
    Ohno, Tsuenya 1368061*

  • Complex of modafinil and cyclodextrin
    Cephalon 1368063*

  • Tetradentate peptide-chelate conjugates for colorectal cancer diagnosis
    Amersham 1368064*

  • You may also like